Holen Sie sich die Stockscreener-App
59.58
3.23%
-1.99
Handel nachbörslich:
59.60
0.02
+0.03%
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
What's Going On With Tonix Pharmaceuticals (TNXP) Stock? - inkl
Traders Consider Averaging Down in Tonix Pharmaceuticals Holding Corp.Market Growth Summary & Reliable Entry Point Trade Alerts - beatles.ru
What is Tonix Pharmaceuticals Holding Corp.’s valuation compared to sectorWeekly Market Outlook & AI Enhanced Execution Alerts - 선데이타임즈
Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Are In A Position To Invest In Growth - Yahoo Finance
Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic - Stocktwits
Tonix Pharma: Eyes On FDA Deadline This Friday, I See A 65% Approval Potential (TNXP) - Seeking Alpha
Tonix Pharmaceuticals Stock (TNXP) Opinions on Recent Price Surge - Quiver Quantitative
Tonix Pharmaceuticals Reports Q2 2025 EPS Loss of $3.86, Beating Estimates; Revenue Falls Short at $2.0 Million - GuruFocus
TNXP Stock Surges: Analyzing Recent Performance - timothysykes.com
Tonix Pharmaceuticals Confirms Cash Stability as Fibromyalgia Campaign Gains Traction - StocksToTrade
Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst - Benzinga
Tonix Pharmaceuticals’ Financial Future: Strong Indicators Signal Positive Outlook - timothysykes.com
Tonix Pharmaceuticals shares rise 1.47% premarket after announcing new data on Mpox and Smallpox vaccine candidate TNX-801. - AInvest
Tonix Pharmaceuticals Narrows Losses And Eyes New Drug Approval - Finimize
Tonix Pharmaceuticals shares rise 2.29% after-hours after announcing new data on Mpox and Smallpox vaccine candidate TNX-801. - AInvest
Tonix Pharma earnings beat by $2.97, revenue fell short of estimates - Investing.com South Africa
Tonix Pharmaceuticals reports Q2 net loss of $28.3 mln - MarketScreener
Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights - GlobeNewswire
Top Biotech Penny Stocks to Watch Out for in August 2025 - StocksToTrade
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga
Tonix Pharmaceuticals Innovation: What’s Next? - timothysykes.com
TNXP’s Race Against Time: Market Buzz Remains High - StocksToTrade
Tonix Pharmaceuticals Holding Corp. Added to Custom Quant Screener TodayMarket Entry and Exit Point Tips From Traders - metal.it
Published on: 2025-08-04 09:31:49 - metal.it
What institutional investors are buying Tonix Pharmaceuticals Holding Corp. stockInvest confidently with professional market insights - Jammu Links News
How does Tonix Pharmaceuticals Holding Corp. compare to its industry peersOutstanding growth strategies - Jammu Links News
When is Tonix Pharmaceuticals Holding Corp. stock expected to show significant growthFree AI-Backed Trading Signals - Jammu Links News
How strong is Tonix Pharmaceuticals Holding Corp. company’s balance sheetCapitalize on high-yield stocks early - Jammu Links News
Should I hold or sell Tonix Pharmaceuticals Holding Corp. stock in 2025Phenomenal wealth increase - Jammu Links News
Is Tonix Pharmaceuticals Holding Corp. a growth stock or a value stockUnprecedented growth rates - Jammu Links News
Published on: 2025-08-03 07:26:37 - Jammu Links News
Does Tonix Pharmaceuticals Holding Corp. stock perform well during market downturnsDynamic profit opportunities - Jammu Links News
How volatile is Tonix Pharmaceuticals Holding Corp. stock compared to the marketUnlock high-yield investment opportunities - Jammu Links News
Why is Tonix Pharmaceuticals Holding Corp. stock attracting strong analyst attentionWealth Building Opportunities For Beginners - Jammu Links News
What are the technical indicators suggesting about Tonix Pharmaceuticals Holding Corp.Chart Pattern Report Backed By Experts - Jammu Links News
Key resistance and support levels for Tonix Pharmaceuticals Holding Corp.Early Entry Picks Before News Breakout Reviewed - metal.it
Tonix launches Move Fibro Forward campaign to support millions living with Fibromyalgia - Proactive financial news
Price Channel Expanding on Tonix Pharmaceuticals Holding Corp.’s ChartLow Risk Swing Trade Opportunities Identified - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500 - Smartkarma
Published on: 2025-07-29 17:18:40 - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500… - Yahoo Finance
Published on: 2025-07-29 07:17:10 - metal.it
What are Tonix Pharmaceuticals Holding Corp. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com
What is the risk reward ratio of investing in Tonix Pharmaceuticals Holding Corp. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Is Tonix Pharmaceuticals Holding Corp. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - jammulinksnews.com
What makes Tonix Pharmaceuticals Holding Corp. stock price move sharplyHigh-return market picks - jammulinksnews.com
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):